CD44 and breast neoplasm: Thus, it is possible that when Luminal-A breast tumor cells are exposed to multiple factors of the TME simultaneously - as recapitulated in our study by the combined TME Stimulation - the CSC sub-population is enriched in parallel to the CD44+/β1+ sub-population.